1. Cabarcas-Petroski, Stephanie, Meneses, Patricio I, Schramm, Laura. 2020. A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma. In BMC cancer, 20, 1093. doi:10.1186/s12885-020-07569-8. https://pubmed.ncbi.nlm.nih.gov/33176745/
2. Gouge, Jerome, Satia, Karishma, Guthertz, Nicolas, Hernandez, Nouria, Vannini, Alessandro. . Redox Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2. In Cell, 163, 1375-87. doi:10.1016/j.cell.2015.11.005. https://pubmed.ncbi.nlm.nih.gov/26638071/
3. Koo, Jana, Cabarcas-Petroski, Stephanie, Petrie, John L, White, Robert J, Schramm, Laura. 2015. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein. In BMC cancer, 15, 905. doi:10.1186/s12885-015-1914-5. https://pubmed.ncbi.nlm.nih.gov/26573593/
4. Sui, RongCui, Liu, ChengCheng, Wang, Na, Zhang, XianZhao, Xu, AnTing. 2021. TFIIB-related factor 2 regulates glucose-regulated protein 78 expression in acquired middle ear cholesteatoma. In Biochemical and biophysical research communications, 540, 95-100. doi:10.1016/j.bbrc.2020.12.052. https://pubmed.ncbi.nlm.nih.gov/33453679/
5. Lockwood, William W, Chari, Raj, Coe, Bradley P, Lam, Stephen, Lam, Wan L. 2010. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. In PLoS medicine, 7, e1000315. doi:10.1371/journal.pmed.1000315. https://pubmed.ncbi.nlm.nih.gov/20668658/
智鼠故事 
